BMJ Case Reports 2017; doi:10.1136/bcr-2017-221118
  • Reminder of important clinical lesson

Lupus miliaris disseminatus faciei: a distinctive facial granulomatous eruption

  1. Gomathy Sethuraman1
  1. 1 Department of Dermatology , All India Institute of Medical Sciences, New Delhi, India
  2. 2 Department of Pathology, All India Institute of Medical Sciences, New Delhi, India
  1. Correspondence to Prof. Gomathy Sethuraman, aiimsgsr{at}
  • Accepted 15 June 2017
  • Published 14 July 2017


Facial granulomatous papules are important to recognise, as some of them are associated with significant systemic association, particularly sarcoidosis and certain infectious conditions. Lupus miliaris disseminatus faciei (LMDF) is a benign granulomatous disorder of unknown aetiology characterised by symmetrical, monomorphic, reddish-brown papules on the face. It is not associated with any underlying systemic involvement. We report a case of LMDF in a middle-aged man who presented to us with multiple asymptomatic and monomorphic reddish papules on the face for 3 months. Skin biopsy showed well-formed perifollicular epithelioid cell granulomas with focus of necrosis suggestive of LMDF. The lesions significantly responded to oral steroids.


  • Contributors TD, TT, GS were responsible for patient evaluation, care and treatment. ML was responsible for histopathological evaluation. TD and GS wrote the manuscript. All authors critically revised and approved for submission.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Register for free content

The full text of all Editor's Choice articles and summaries of every article are free without registration

The full text of Images in ... articles are free to registered users

Only fellows can access the full text of case reports (apart from Editor's Choice) - become a fellow today, or encourage your institution to, so that together we can grow and develop this resource

Don't forget to sign up for content alerts so you keep up to date with all the case reports as they are published, and let us know what you think by commenting on the Editor's blog

Navigate This Article